WE OPERATE ON THREE CONTINENTS
We care for the health of more than 300 million people

Bosnalijek in the World


Company Profile   
Corporate Responsibility   
Company Management
Bosnalijek in the World
septembar 26. 2023 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%
ABOUT US Company Profile Corporate Responsibility Company Management Bosnalijek in the World
PRODUCTS
Search products by trade name Search products by generic name
INVESTORS Quarterly Reports Audit Report Financial News Shareholders’ Meeting Useful Links
PRESS CENTRE News Press Kit Corporate and Visual Identity Video Gallery Photo Gallery Media Contact
CAREER Career with Bosnalijek Principles and Values How is it to work at Bosnalijek? Employment Vacancies Contact Information
OUR PAGES ALTIOX® Royal Jelly® Alerix® Enterofuryl STOP® Rhinostop® Lysobact® Fenix NEO® Lynase® Rhinostop® HOT MECOBALAMIN D3 SPRAY® DOLOREX® Lysoderm® Oralni mukozitis